Your browser doesn't support javascript.
loading
RMI2 is a novel prognostic and predictive biomarker for breast cancer.
Zhang, Lijie; Hao, Chuncheng; Han, Baojuan; Zeng, Guangchun; Han, Lili; Cao, Cong; Liu, Hui; Zhong, Zhenbin; Zhao, Xue; Wang, Jingxuan; Zhang, Qingyuan.
Afiliación
  • Zhang L; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Hao C; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Han B; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zeng G; Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Han L; Department of Orthopedic Surgery, The First Hospital of Suihua, Suihua, China.
  • Cao C; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Liu H; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhong Z; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhao X; Department of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Wang J; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhang Q; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Cancer Med ; 12(7): 8331-8350, 2023 04.
Article en En | MEDLINE | ID: mdl-36533385

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article